- $2.85m
- $1.31m
- $2.00m
Brief: Bioatla Announces Fourth Quarter And Full Year 2021 Financial Results
U.S. RESEARCH ROUNDUP-CVS Health, Shopify, WEX
U.S. RESEARCH ROUNDUP- Exxon Mobil, JP Morgan, Wells Fargo & Co
Brief: BioAtla Announces Clinical Collaboration With Bristol Myers Squibb To Study Mecbotamab Vedotin (Ba3011) And Ozuriftamab Vedotin (Ba3021) In Combination With Opdivo® (Nivolumab) For Treatment Of Solid Tumors
Development And Collaboration Agreement With Beigene
U.S. RESEARCH ROUNDUP-Datadog, Home Depot, Walmart
Brief: Bioatla Expects Current Cash And Cash Equivalents To Be Sufficient To Fund Planned Operations Into First Half Of 2024
Brief: Bioatla Inc Files Prospectus Relates To Resale, From Time To Time, Of Up To 2.7 Million Shares Of Common Stock By Selling Stockholders
Brief: Bioatla Inc Announces Private Placement Of 2.7 Mln Shares
Brief: Bioatla Announces Second Quarter 2021 Financial Results And Provides Clinical Update
U.S. RESEARCH ROUNDUP-Churchill Downs, Doordash, MercadoLibre,
Bioatla Inc reports results for the quarter ended in March - Earnings Summary
Brief: Bioatla Posts Q1 Net Loss Of $18.7 Million
U.S. RESEARCH ROUNDUP-Ashland Global Holdings, Dollar General, Facebook
Brief: BioAtla Announces Full Year 2020 Financial Results
Brief: Pfizer Reports Passive Share Stake Of 7% In BioAtla As Of Dec. 31
U.S. RESEARCH ROUNDUP- Anaplan, Datadog, Intersect Ent
Brief: HBM Healthcare Investments (Cayman) Ltd Reports A Passive Stake Of 8.8% In Bioatla Inc As Of December 15 - SEC Filing
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM